Abstract
It is shown that Meso-Inositol Hexanicotinate (MIHN; Hexopal) inhibits experimentally induced oedema of the paw in rats and that mice exposed to hypoxic atmospheres (4% oxygen) show significant increase in survival time if pre-dosed with MIHN. The protection against oedema and hypoxia conferred by MIHN in experimental animals may well be related to the mode of action of the substance in man, and particularly could explain the usefulness of MIHN in the treatment of cerebral and peripheral atherosclerosis.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
